Senior living operators ‘incredibly agile and dedicated’ during COVID-19 pandemic: study
By
Kimberly Bonvissuto
Oct 29, 2021
Senior living and care providers have been “incredibly agile and dedicated” during the pandemic, working 24 / 7 to keep residents safe, researchers concluded after interviews with operators about their...
FDA adds Guillain-Barré warning to J&J COVID-19 vaccine
Jul 12, 2021
Approximately 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered.
DOJ appeals court-ordered temporary stay of OSHA vaccine rule
By
Kathleen Steele Gaivin
Nov 11, 2021
After a three-judge panel on the Fifth Circuit Court of Appeals temporarily blocked the Biden administration’s new mandatory vaccination rules Saturday, the Department of Justice responded late Monday,...
Voting mostly along party lines, the Senate voted Tuesday to nullify the Biden administration’s vaccinate-or-test mandate for companies with 100 or more employees.
Allergic reactions to mRNA COVID-19 vaccines characterized
Sep 20, 2021
20 of 22 patients with suspected allergic reactions were women; 17 met Brighton anaphylaxis criteria.
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.
In 11 states, seniors’ low vaccination rates a ‘powder keg’ for new cases
Jun 21, 2021
In states where vaccination rates are low, seniors who have not gotten a shot pose a public health risk as social-distancing restrictions are stripped away.
Senators introduce bill calling for $1.5B to help seniors cope with the effects of COVID-19
By
Joe Jancsurak
Feb 26, 2021
In recognition of the soaring demand for senior services during the COVID-19 pandemic, U.S. Sens. Bob Casey (D-PA), Mark Kelly (D-AZ) and Kirsten Gillibrand (D-NY) introduced on Thursday the Continued...
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.